Medications that target ACE and angiotensin receptors, such as angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs), respectively, are widely used as antihypertensive agents and therapies for patients with heart failure and diabetic complications [94]. This evidence concerns the gene ACE and heart failure.